Anne Andrews to Cost-Benefit Analysis
This is a "connection" page, showing publications Anne Andrews has written about Cost-Benefit Analysis.
Connection Strength
0.443
-
A Cost-Effectiveness Analysis of Obtaining Blood Cultures in Children Hospitalized for Community-Acquired Pneumonia. J Pediatr. 2015 Dec; 167(6):1280-6.
Score: 0.116
-
The cost of Medicaid savings: the potential detrimental public health impact of neonatal circumcision defunding. Infect Dis Obstet Gynecol. 2012; 2012:540295.
Score: 0.094
-
A cost-effectiveness analysis of dexamethasone versus prednisone in pediatric acute asthma exacerbations. Acad Emerg Med. 2012 Aug; 19(8):943-8.
Score: 0.093
-
A cost-effectiveness analysis of inhaled corticosteroid delivery for children with asthma in the emergency department. J Pediatr. 2012 Nov; 161(5):903-7.
Score: 0.092
-
Cost-effectiveness analysis of annual Trichomonas vaginalis screening and treatment in HIV-positive women to prevent HIV transmission. Sex Transm Dis. 2014 Jun; 41(6):353-8.
Score: 0.026
-
A cost-effectiveness analysis of anal cancer screening in HIV-positive women. J Low Genit Tract Dis. 2012 Jul; 16(3):275-80.
Score: 0.023